| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Bill.com Holdings (BILL) | Goldman Sachs/ BofA Securities/ Jefferies/ KeyBanc Capital Markets | $100.00 | n.a. | |||
| CDP Holdings (CDP) | BofA Securities/ Citigroup | $125.00 | n.a. | |||
| Hitek Global (HKIT) | Newbridge Securities/ WestPark Capital | 1.80 | $4.00 | $6.00 | $9.00 | n.a. |
| OneConnect Financial Technology (OCFT) | Morgan Stanley/ Goldman Sachs (Asia)/ J.P. Morgan/ Ping An of China Securities (Hong Kong) | $100.00 | n.a. | |||
| Oriental Culture Holding (DFWH) | ViewTrade Securities | 2.50 | $4.00 | $4.00 | $10.00 | n.a. |
| Reynolds Consumer Products (REYN) | Credit Suisse/ Goldman Sachs/ J.P. Morgan | $100.00 | n.a. | |||
| XP Inc. (XP) | Goldman Sachs/ J.P. Morgan/ Morgan Stanley/ XP Investments/ Itaú BBA | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Inhibrx (INBX) | Evercore ISI/ Barclays/ Nomura | $74.75 | n.a. | |||
| New Terms | ||||||
| 89bio (ETNB) | BofA Merrill Lynch/ SVB Leerink/ RBC Capital Markets | 5.30 | $16.00 | $16.00 | $84.87 | S/O |
| AnPac Bio-Medical Science (ANPC) | WestPark Capital | 1.67 | $12.00 | $14.00 | $21.67 | S/O |
| Canaan (CAN) | Citigroup/ China Renaissance/ CMBI | 10.00 | $9.00 | $11.00 | $100.00 | S/O |
| YX Asset Recovery Limited (YXR) | Deutsche Bank Securities/ CMBI/ Raymond James/ AMTD Global Markets/ SunTrust Robinson Humphrey | 9.28 | $7.75 | $9.75 | $81.22 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Nov. 11, 2019 | Manager(s) | Offered | Raised | Price | 11/15/19 | Change |
| 89bio (ETNB) | BofA Merrill Lynch/ SVB Leerink/ RBC Capital Markets | 5.30 | $84.87 | $16.00 | $27.00 | 68.75% |
| YayYo (YAYO) | Aegis Capital/ WestPark Capital | 2.63 | $10.50 | $4.00 | $3.60 | -10.00% |
